InsidersTradesSigma
Track the PHARMANUTRA FIRST HALF 2023 RESULTS stock price and the full directors' dealings record of the company, a listed equity based in Italy. Shares are quoted on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA FIRST HALF 2023 RESULTS has recorded 0 reports. Market capitalisation: €784.2m. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
PHARMANUTRA reported its results for the first half of 2023, demonstrating strong performance in the health and pharmaceutical sector. The company is listed on the XMIL market.